ByTrending Posts
Rakovina Therapeutics and Variational AI Partner to Advance…
Vancouver, BC – September 17, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV), a Canadian biopharmaceutical company focused on developing…
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic…
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have entered into a…
Sanofi Taps Atomwise in $1B+ AI Drug Pact…
Key Highlights San Francisco — Atomwise, a pioneer in artificial intelligence for small molecule drug discovery, has entered…
How Stryker’s Acquisition of care.ai Strengthens Its Push…
Stryker to acquire care.ai to elevate virtual care workflows and expand its healthcare IT leadership Portage, Michigan –…
AI-Powered Clinical Trials: How Unlearn AI, AbbVie, and…
July 30, 2024 Artificial intelligence (AI) is revolutionizing clinical trials, offering greater efficiency and precision. At the Alzheimer’s…
CytoReason Raises $80M from OurCrowd, NVIDIA, Pfizer &…
New funding will scale CytoReason’s AI platform, expand disease models, and support a new office in Cambridge, MA.…
GSK Partners with Ochre Bio in $37.5 Million…
London, UK – June 12 2024 GSK has entered into a $37.5 million strategic partnership with Ochre Bio…
Sanofi, Formation Bio, and OpenAI Forge Strategic Alliance…
Paris, New York, N.Y., and San Francisco, CA — May 21, 2024 Sanofi, Formation Bio, and OpenAI have…
Recursion Unveils BioHive-2: The World’s Largest AI Supercomputer…
Salt Lake City – May 13, 2024 Recursion Pharmaceuticals, a leading clinical-stage TechBio company, has announced the completion…
Trending Posts
Latest Stories
Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca…
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug…
Gallery
